Official announcements
messages in brief
|
31/03/2009
In January 2009, AGES PharmMed conducted the second customer survey since its foundation in 2006. As in the previous survey, marketing authorization holders of proprietary medicinal products were addressed. In contrast to the first survey, the survey…
messages in brief
|
23/03/2009
BASG/AGES PharmMed warn against the use of the weight loss tea "Paiyouji". Analyses in the Austrian Drug Control Laboratory (OMCL of AGES PharmMed) showed that this product contains a possibly carcinogenic indicator substance as well as a chemical…
messages in brief
|
22/03/2009
In 2006, after the completion of the major review of pharmaceutical legislation, the Commission published ideas to further improve the legislation of proprietary medicinal product variation applications. The basic idea was: Simplification of…
Safety warnings
|
Blood & Tissue
|
13/10/2008
Re-emergence of a case in Bucharest.
Safety warnings
|
Blood & Tissue
|
08/10/2008
Occurrence of a confirmed case in the province of Bologna/Ferrara.
Recall
|
Medicines
|
29/09/2008
The following quality defect has been identified in the drug product Ionsys (Fentanyl) 40 microgram per dose iontophoretic transdermal system: A defect in the IONSYS systems may potentially cause the system to self-activate. See related files.
Replacement
|
Medicines
|
18/08/2008
Exchange of unbuffered and weakly buffered infusion solutions. See associated files.
Medicines
|
18/01/2008
Communication from the Federal Office for Safety in Health Care on Gardasil. You related file.
Recall
|
Medicines
|
06/11/2007
Information on the suspension of marketing of parenterally administrable drug products containing aprotinin. See related files.